Abstract
5-chloro-7-iodo-quinolin-8-ol (clioquinol) is a copper-binding halogenated 8-hydroxyquinoline that was used in the 1950s-1970s as an oral antiparasitic agent for the treatment and prevention of intestinal amebiasis. In the 1970s oral clioquinol was withdrawn from the market due to reports of neurotoxicity in Japanese patients. However, topical formulations of clioquinol are still available for the treatment of topical fungal and parasitic infections. Recently, clioquinol has reemerged for the treatment of non-infectious indications including malignancy and .... . © 2009
| Original language | English |
|---|---|
| Title of host publication | xPharm |
| Subtitle of host publication | The Comprehensive Pharmacology Reference |
| Editors | S.J. Enna, David B. Bylund |
| Publisher | Elsevier Inc. |
| Pages | 1-5 |
| Number of pages | 5 |
| ISBN (Print) | 9780080552323 |
| DOIs | |
| State | Published - 2009 |
| Externally published | Yes |
ASJC Scopus Subject Areas
- General Pharmacology, Toxicology and Pharmaceutics
Disciplines
- Medicine and Health Sciences
Fingerprint
Dive into the research topics of 'Clioquinol'. Together they form a unique fingerprint.Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS